University of Alabama Medicine 2020 ASCO Highlights

 

Videos
16:36

University of Alabama Medicine 2020 ASCO Highlights

UAB ASCO 2020 Updates on HIF Inhibitors in Advanced RCC: Does Belzutifan Prolong PFS?

FEATURING Arnab Basu
  • 42 views
  • December 7, 2020
13:07

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Highlights on Newly Diagnosed MM: KRd vs. VRd - Are There Differences in Toxicities? Is Addition of Elotuzumab Beneficial in High-Risk Disease? Does Dexamethasone Induce MRD-Negative Remission?

FEATURING Susan Bal
  • 19 views
  • October 20, 2020
05:17

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Highlights on Advanced NSCLC: What Is the Clinical Benefit of Nivo+Ipi in Advanced NSCLC? How Effective Is 1L Nivo/Ipi/CT Combination?

FEATURING Devika Das
  • 23 views
  • September 9, 2020
06:56

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on EGFR+ mNSCLC: Should We Incorporate Osimertinib Into Standard Practice? Is T-DXd a Promising Option for HER2+ Disease?

FEATURING Devika Das
  • 113 views
  • September 9, 2020
13:57

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO IMvigor 130 Bladder Cancer Updated Results: Does the Addition of IO to Chemo Improve OS and PFS? What About Sequencing Immunotherapy With Atezo After Chemo?

FEATURING Lakshminarayanan Nandagopal
  • 206 views
  • September 9, 2020
09:38

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Advanced RCC: Are We Over-Treating Patients With Nivo + Ipi? What Is the Role of HIF-2 in Kidney Cancer? Is Bev/Erlotinib Combination Safe in pRCC and HLRCC?

FEATURING Lakshminarayanan Nandagopal
  • 29 views
  • September 9, 2020
07:32

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Prostate Cancer: How Effective Is Enzalutamide in nmCRPC? Does Relugolix Help Patients With Advanced PC and Is Theranostics the Future?

FEATURING Lakshminarayanan Nandagopal
  • 118 views
  • September 9, 2020
  • 1
15:11

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on CP-CML: What Dose of Ponatinib Is Both Safe and Effective?

FEATURING Pankit Vachhani
  • 12 views
  • September 9, 2020
10:41

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on R/R AML: What AMG 330 Dosage Is Safe and Tolerable With Anti-Leukemic Activity?

FEATURING Pankit Vachhani
  • 178 views
  • September 9, 2020
08:27

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Frontline AML: Does the Addition of Venetoclax Lead to Improved Response in Patients Ineligible for Intensive Therapy?

FEATURING Pankit Vachhani
  • 135 views
  • September 9, 2020
  • 1
07:10

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in AML: Are Aza/Ven/Ivosidenib Combination Well Tolerated and Effective in Patients With IDH1-Mutated Disease?

FEATURING Pankit Vachhani
  • 43 views
  • September 9, 2020
08:08

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Frontline AML: What Is the Effect of Enasidenib + Aza on Complete Remission and Overall Response vs. Aza Monotherapy in IDH2-Mutant Disease?

FEATURING Pankit Vachhani
  • 67 views
  • September 9, 2020
13:15

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Myeloid Malignancies: Is Aza/Pevonidistat More Effective than Azacitidine Monotherapy in Higher-Risk MDS/CMML/AML? How Effective Is Aza/Magrolimab Combination in Untreated AML/MDS?

FEATURING Pankit Vachhani
  • 80 views
  • September 9, 2020
12:24

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on mBC: Do Surgery and Radiation After Initial Systemic Therapy Extend Survival in Newly Diagnosed Metastatic Breast Cancer?

FEATURING Erica Stringer-Reasor
  • 354 views
  • September 9, 2020
  • 4
11:17

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on PIK3CA HR+ BC: Is Alpelisib Effective After CDK4/6 Inhibition in Advanced Breast Cancer?

FEATURING Erica Stringer-Reasor
  • 632 views
  • September 9, 2020
  • 5
14:19

University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on CAR-T in Lymphoma: First CD19/22 Dual Targeting CAR-T, ALLO-501 & ALLO-647 in R/R LBCL/FL, Axi-Cel in R/R iNHL

FEATURING Amitkumar Mehta
  • 122 views
  • August 25, 2020
  • 1